Sign in

Kole DeGolier

@koledegolier.bsky.social
29 followers 28 following 7 posts

Ph.D. | Immunology Postdoctoral Research Fellow Lab of James Scott-Browne, Ph.D. National Jewish Health, Denver, CO Cancer immunotherapy, immunology, epigenetic mechanisms controlling T cell fate

PostsRepliesMedia
Reposted by Kole DeGolier
Marion Pepper @marionpepper.bsky.social · 22/01/2025
No functional NIH…no US scientists that spend their days making discoveries that save lives and drive US innovation and economic growth. This will negatively impact all Americans.
0127
Reposted by Kole DeGolier
E John Wherry @ejohnwherry.bsky.social · 23/01/2025
Yes. Exactly. One of (if not THE) best ROI for any govt spending.
24519
Kole DeGolier @koledegolier.bsky.social · 02/01/2025
I am thrilled to share my first-ever first author publication in Nature Immunology as my first post on Bluesky! Huge thanks to everyone who contributed to this work! See comments for more. #celltherapy #immunology #immunotherapy #CARTcells www.nature.com/articles/s41...
nature.com
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response - Nature Immunology
Here, Fry and colleagues examine the impact of antigen experience on subsequent CD8+ CAR T cell activity during the antileukemia response and show that RUNX2 overexpression enhances antitumor activity...
7125